Vnitr Lek 2008, 54(5):535-540

Metformin and kidneys

A. Šmahelová
Diabetologické centrum Kliniky gerontologické a metabolické Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Luboš Sobotka, CSc.

Metformin is currently recommended as the first-line drug for type 2 diabetic patients once the disease has been diagnosed. In addition to antihyperglycaemic effect, it has other effects which have a positive effect on cardiovascular risk. The greatest risk of metformin treatment is lactate acidosis, but its incidence is very low if the contraindications are observed. In spite of the fact that not all contraindications are observed in practice, the incidence of lactate acidosis demonstrably provoked by metformin does not grow. In spite of ongoing discussion on the subject, contraindications still include all states involving the risk of lactacidosis including renal insufficiency.

Keywords: metformin; renal function; lactate acidosis; metformin contraindications

Received: March 24, 2008; Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šmahelová A. Metformin and kidneys. Vnitr Lek. 2008;54(5):535-540.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Calabrese AT, Coley KC et al. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002; 2: 434-437. Go to original source... Go to PubMed...
    2. Gomes MB, Cailleaux S, Solange C et al. Effects of metformin on endothelial dysfunction of the renal circulation resulting from acute hyperglycemia in non-diabetic rabbits. Arq Bras Endocrinol Metab 2005; 49: 938-994. Go to original source... Go to PubMed...
    3. Holstein A, Stumvoll M. Contraindications can damage your health - is metformin a case in point? Diabetologia 2005; 48: 2454-2459. Go to original source... Go to PubMed...
    4. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes & Metabolism 2000; 26: 73-85. Go to PubMed...
    5. Killop AM, Duffy NA, Lindsay H et al. Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects. Diabetes Res Clin Pract 2007; 273: 157-169. Go to original source...
    6. Krentz AJ. Insulin Resistance: a clinical handbook. Osney Mead, Oxford: Blackwell Science a Blackwell Publishing Company 2002. Go to original source...
    7. Lebovitz HE. Therapy for Diabetes Mellitus and Related Disorders. 4th ed. Alexandria: American Diabetes Association: 2004.
    8. Lindsay JR, Duffy NA, McKillop AM et al. Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes. Diabet Med 2005; 22: 654-657. Go to original source... Go to PubMed...
    9. Mithieux G, Rajas F, Zitoun C. Glucose utilization is suppressed in the gut of insulin-resistant high fat-fed rats and is restored by metformin. Biochem Pharmacol 2006; 72: 198-203. Go to original source... Go to PubMed...
    10. Orban JC, Giunti C, Levraut J et al. L'acidose lactique reste une complication grave du traitement par metformine = Metformin-associated lactic acidosis remains a serious complication of metformin therapy. Ann Fr Reanim, 2003; 22: 461-465. Go to original source... Go to PubMed...
    11. Rachmani R, Slavachevski I, Levi Z et al. Metformin in patients with type 2 diabetes melllitus: reconsideration of traditional contraindications. Eur J Intern Med 2002; 13: 428-433. Go to original source... Go to PubMed...
    12. Salpeter SR, Greyber E, Pasternak GA et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and metaanalysis. Arch Intern Med 2002; 163: 2594-2602. Go to original source... Go to PubMed...
    13. Stang M, Wysowsk DK, Hitler-Jones D. Incidence of lactic acidosis in metformin users. Diab Care 1999; 22: 925-992. Go to original source... Go to PubMed...
    14. Šmahelová A. Akutní komplikace diabetu. Praha: Triton 2006.
    15. Tanihara Y, Masuda S, Katsura H et al. Subtrate specificity of MATE1 and MATE2-K, human multidrug and toxin sextrusions/H(+)-organic antiporters. Biochem Pharmacol 2007; 74: 359-371. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.